JP2007530595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530595A5 JP2007530595A5 JP2007505245A JP2007505245A JP2007530595A5 JP 2007530595 A5 JP2007530595 A5 JP 2007530595A5 JP 2007505245 A JP2007505245 A JP 2007505245A JP 2007505245 A JP2007505245 A JP 2007505245A JP 2007530595 A5 JP2007530595 A5 JP 2007530595A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- agent
- heteroatoms
- independently
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55676604P | 2004-03-26 | 2004-03-26 | |
| US11/089,701 US7462612B2 (en) | 2004-03-26 | 2005-03-25 | Pyridine inhibitors of ERK2 and uses thereof |
| PCT/US2005/010204 WO2005100342A1 (en) | 2004-03-26 | 2005-03-25 | Pyridine inhibitors of erk2 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530595A JP2007530595A (ja) | 2007-11-01 |
| JP2007530595A5 true JP2007530595A5 (cg-RX-API-DMAC10.html) | 2008-05-08 |
Family
ID=34964893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007505245A Pending JP2007530595A (ja) | 2004-03-26 | 2005-03-25 | Erk2のピリジンインヒビターおよびそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7462612B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1730134A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2007530595A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005100342A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006087548A2 (en) * | 2005-02-18 | 2006-08-24 | Astrazeneca Ab | Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| EP1879881A2 (en) * | 2005-04-14 | 2008-01-23 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| US7855289B2 (en) | 2005-08-04 | 2010-12-21 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8088928B2 (en) | 2005-08-04 | 2012-01-03 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| CN101253152A (zh) | 2005-09-02 | 2008-08-27 | 安斯泰来制药株式会社 | 作为rock抑制剂的酰胺衍生物 |
| US8546404B2 (en) | 2005-12-13 | 2013-10-01 | Merck Sharp & Dohme | Compounds that are ERK inhibitors |
| JP2009528280A (ja) | 2006-02-16 | 2009-08-06 | シェーリング コーポレイション | Erkインヒビターとしてのピロリジン誘導体 |
| EP2032562B1 (en) * | 2006-05-12 | 2010-08-25 | Vertex Pharmaceuticals Incorporated | Selective inhibitors of rock protein kinase and uses thereof |
| BRPI0713187A2 (pt) * | 2006-07-20 | 2012-10-16 | Mehmet Kahraman | método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica |
| CA2663436A1 (en) | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| CN101611007A (zh) * | 2006-12-20 | 2009-12-23 | 先灵公司 | 新颖的jnk抑制剂 |
| TW200916472A (en) | 2007-06-20 | 2009-04-16 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
| CA2696349A1 (en) | 2007-08-15 | 2009-02-19 | President And Fellows Of Harvard College | Heterocyclic inhibitors of necroptosis |
| CN102015693B (zh) | 2008-02-21 | 2014-10-29 | 默沙东公司 | 作为erk抑制剂的化合物 |
| CN102388054B (zh) | 2008-12-19 | 2015-03-04 | 西特里斯药业公司 | 噻唑并吡啶沉默调节蛋白调节剂的化合物 |
| JP5502397B2 (ja) * | 2009-08-25 | 2014-05-28 | 公益財団法人微生物化学研究会 | 新規化合物アミコロース誘導体、並びにその製造方法及びその用途 |
| CN103420902A (zh) * | 2012-05-18 | 2013-12-04 | 苏州爱斯鹏药物研发有限责任公司 | 一种2-氯-4-碘-5-甲基吡啶的制备方法 |
| WO2014145022A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| CN103193704B (zh) * | 2013-04-12 | 2016-03-09 | 四川铂瑞生物医药有限公司 | 2-羟基-4-氨基-5-甲基吡啶杂环化合物 |
| US20160264536A1 (en) * | 2013-10-23 | 2016-09-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US12048761B2 (en) | 2015-10-13 | 2024-07-30 | Inserm (Institut National De La Santé Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion |
| US20190073895A1 (en) * | 2017-09-07 | 2019-03-07 | Timetec Holding Sdn Bhd | Alarm system |
| AU2020230965A1 (en) | 2019-03-05 | 2021-09-23 | Bayer Aktiengesellschaft | Synthesis of 4-amino-5-methyl-1H-pyridin-2(1H)-on (intermediate compound for the synthesis of the MR antagonist finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide using the intermediate compound 2-chloro-5-methyl-4-pyridinamine |
| CN113929591A (zh) * | 2021-10-09 | 2022-01-14 | 中国科学技术大学 | 具有抗增殖活性的抑制剂 |
| CN117024335A (zh) * | 2023-07-10 | 2023-11-10 | 杭州小蓓医药科技有限公司 | 一种非奈利酮中间体4-氨基-5-甲基-1h-吡啶-2(i)-酮的合成工艺 |
| WO2025224050A1 (en) | 2024-04-22 | 2025-10-30 | Institut National de la Santé et de la Recherche Médicale | Methods of treatment of patients suffering from hypomelanosis of ito |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1274295A (en) | 1993-12-30 | 1995-07-17 | Ciba-Geigy Ag | Heteroarylpyrroles |
| US5776954A (en) * | 1996-10-30 | 1998-07-07 | Merck & Co., Inc. | Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| JP4783532B2 (ja) * | 2000-02-05 | 2011-09-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | Erkのインヒビターとして有用なピラゾール組成物 |
| EP1506189A1 (en) * | 2002-04-26 | 2005-02-16 | Vertex Pharmaceuticals Incorporated | Pyrrole derivatives as inhibitors of erk2 and uses thereof |
| BR0317430A (pt) * | 2002-12-20 | 2005-10-25 | Pharmacia Corp | Compostos inibidores de quinase-2 de proteìna ativada por quinase de proteìna ativada por mitógeno |
| CA2515132C (en) | 2003-02-07 | 2012-01-03 | Vertex Pharmaceuticals Incorporated | Heteroaryl substituted pyrroles useful as inhibitors of protein kinases |
| ES2897422T3 (es) * | 2004-05-14 | 2022-03-01 | Vertex Pharma | Compuestos pirroles como inhibidores de proteínas cinasas ERK y composiciones farmacéuticas que contienen esos compuestos |
-
2005
- 2005-03-25 WO PCT/US2005/010204 patent/WO2005100342A1/en not_active Ceased
- 2005-03-25 JP JP2007505245A patent/JP2007530595A/ja active Pending
- 2005-03-25 EP EP05733207A patent/EP1730134A1/en not_active Withdrawn
- 2005-03-25 US US11/089,701 patent/US7462612B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1865958B1 (en) | Pharmacokinetically improved compounds | |
| CN1113066C (zh) | 新型肽衍生物 | |
| JP2007501257A5 (cg-RX-API-DMAC10.html) | ||
| JP2010532380A5 (cg-RX-API-DMAC10.html) | ||
| JP2006520386A5 (cg-RX-API-DMAC10.html) | ||
| JP2020528907A5 (cg-RX-API-DMAC10.html) | ||
| CA2755095A1 (en) | Rho kinase inhibitors | |
| CN1161330A (zh) | 取代的间二氮杂萘衍生物 | |
| JP2006522124A5 (cg-RX-API-DMAC10.html) | ||
| JP2020055828A5 (cg-RX-API-DMAC10.html) | ||
| KR20100099116A (ko) | 리버스턴 유사체의 신규 화합물 및 그의 용도(2) | |
| JP2008528671A5 (cg-RX-API-DMAC10.html) | ||
| EP3277276A1 (en) | Methods of administering glutaminase inhibitors | |
| JP2017214420A5 (cg-RX-API-DMAC10.html) | ||
| JP2014055136A (ja) | 薬物動態が改善された化合物 | |
| JP6785801B2 (ja) | 新しいキャップ基ラルガゾールの類似体の合成及び使用 | |
| RU2006144448A (ru) | Пролекарства пирролилпиримидиновых ингибиторов протеинкиназы erk | |
| KR20230118854A (ko) | IRE1α 억제제 및 이의 용도 | |
| US12357612B2 (en) | Prophylactic or therapeutic agent for cancer | |
| US20130345281A1 (en) | Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment | |
| TWI234457B (en) | Camptothecin-taxoid conjugates as antimitotic and antitumor agents | |
| CN101193861A (zh) | 具有抗肿瘤活性的吲哚衍生物 | |
| CN109152750A (zh) | 用于增殖性疾病的组合疗法 | |
| ES2222988T3 (es) | Formas de sal especificas de derivados de trifeniletileno como moduladores selectivos de los receptores de estrogenos. | |
| JP2007507473A5 (cg-RX-API-DMAC10.html) |